Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019
- PMID: 32330276
- DOI: 10.1001/jamanetworkopen.2020.9035
Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019
Comment on
-
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial.JAMA Netw Open. 2020 Apr 24;3(4):e208857. doi: 10.1001/jamanetworkopen.2020.8857. JAMA Netw Open. 2020. PMID: 32330277 Clinical Trial.
Similar articles
-
Chloroquine and hydroxychloroquine for COVID-19: A word of caution.Respirology. 2020 Jul;25(7):683-684. doi: 10.1111/resp.13845. Epub 2020 May 11. Respirology. 2020. PMID: 32394513 Free PMC article. No abstract available.
-
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.Ann Rheum Dis. 2020 May;79(5):666-667. doi: 10.1136/annrheumdis-2020-217367. Epub 2020 Apr 2. Ann Rheum Dis. 2020. PMID: 32241791 No abstract available.
-
Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.Am J Cardiol. 2020 Sep 1;130:162-163. doi: 10.1016/j.amjcard.2020.06.003. Epub 2020 Jun 9. Am J Cardiol. 2020. PMID: 32624192 Free PMC article. No abstract available.
-
Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2.Biomed Pharmacother. 2020 Nov;131:110668. doi: 10.1016/j.biopha.2020.110668. Epub 2020 Aug 24. Biomed Pharmacother. 2020. PMID: 32861965 Free PMC article. Review.
-
Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?Clin Rheumatol. 2020 Aug;39(8):2461-2465. doi: 10.1007/s10067-020-05202-4. Epub 2020 Jun 3. Clin Rheumatol. 2020. PMID: 32495226 Free PMC article. Review.
Cited by
-
Long COVID in autoimmune rheumatic diseases.Rheumatol Int. 2023 Jul;43(7):1197-1207. doi: 10.1007/s00296-023-05319-0. Epub 2023 Mar 30. Rheumatol Int. 2023. PMID: 36995436 Free PMC article. Review.
-
A scoping review of digital health interventions for combating COVID-19 misinformation and disinformation.J Am Med Inform Assoc. 2023 Mar 16;30(4):752-760. doi: 10.1093/jamia/ocad005. J Am Med Inform Assoc. 2023. PMID: 36707998 Free PMC article. Review.
-
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.PLoS One. 2022 Sep 29;17(9):e0273526. doi: 10.1371/journal.pone.0273526. eCollection 2022. PLoS One. 2022. PMID: 36173983 Free PMC article.
-
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.medRxiv [Preprint]. 2022 Aug 16:2022.01.10.22269008. doi: 10.1101/2022.01.10.22269008. medRxiv. 2022. Update in: PLoS One. 2022 Sep 29;17(9):e0273526. doi: 10.1371/journal.pone.0273526 PMID: 35043124 Free PMC article. Updated. Preprint.
-
Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.Clin Rheumatol. 2022 Jan;41(1):1-18. doi: 10.1007/s10067-021-05805-5. Epub 2021 Jul 3. Clin Rheumatol. 2022. PMID: 34218393 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
